UBS raised the firm’s price target on Exelon (EXC) to $48 from $46 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC:
- ComEd receives approval for Beneficial Electrification Plan 2 from ICC
- Exelon price target lowered to $48 from $49 at Morgan Stanley
- Exelon Corp.’s New Ventures: Navigating Risks in Smart Grids and Electrification
- Exelon downgraded to Underweight from Sector Weight at KeyBanc
- Exelon price target raised to $50 from $46 at Wells Fargo